Analysis of the relationship between invasive capability of Helicobacter pylori and gastroduodenal diseases

Xiaoyan Zhang1, Jie Zhang1, Yunbin Lin1

  • 1Key Laboratory of Ministry of Education for Gastrointestinal Cancer, School of Basic Medical Sciences, Fujian Medical University, Fuzhou 350108, PR China.

Insights

Helicobacter pylori can invade host cells, correlating with disease severity. This invasion activates the NF-κB pathway and induces IL-8 secretion, suggesting a key role in H. pylori-associated diseases.

Area of Science:

  • Microbiology
  • Cell Biology
  • Pathogenesis

Background:

  • Helicobacter pylori (H. pylori) is a pathogen implicated in various gastrointestinal diseases.
  • The intracellular behavior of H. pylori and its role in disease development are not fully understood.

Purpose of the Study:

  • To investigate the intracellular roles of H. pylori in bacterial pathogenesis.
  • To determine the correlation between H. pylori invasion ability and disease severity.
  • To elucidate the signaling pathways activated by intracellular H. pylori.

Main Methods:

  • Transmission electron microscopy to visualize bacterial invasion.
  • Gentamicin invasion assay to quantify invasion rates.
  • Polymerase chain reaction (PCR) to detect virulence genes (cagA, cagE, vacA).
  • DNA sequencing of the cagA 3' region (cagA-EPIYA).
  • ELISA for IL-8 secretion and dual-luciferase reporter assay for NF-κB activity.

Main Results:

  • H. pylori successfully invaded, survived, and multiplied within AGS cells.
  • Higher invasion rates were observed in strains from gastric cancer and ulcer patients compared to gastritis patients (P ≈ 0.0001).
  • Invasion ability correlated positively with H. pylori vacA mid-region genotype (s1c-i1-m1b vs. s1c-i1-m2; P=0.0445).
  • Intracellular H. pylori induced IL-8 secretion and activated the NF-κB pathway, which was inhibited by anti-β1-integrin antibody or an NF-κB inhibitor (SN-50).

Conclusions:

  • H. pylori invasive ability is positively correlated with disease severity and associated with the vacA mid-region.
  • Internalized H. pylori activates the NF-κB signaling pathway, leading to IL-8 secretion.
  • Bacterial invasion represents a significant strategy in the pathogenesis of H. pylori-associated diseases.

Related Concept Videos

Peptic Ulcer01:27

Peptic Ulcer

Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the...
36
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
1.8K
Pathophysiology of Peptic Ulcer Disease: Injurious Factors01:22

Pathophysiology of Peptic Ulcer Disease: Injurious Factors

Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
1.6K
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
1.1K
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
859
Peptic Ulcer Disease II: Pathophysiology01:28

Peptic Ulcer Disease II: Pathophysiology

Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
2.9K